Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program

Cometta, A ; Calandra, T ; Gaya, H ; Zinner, S H ; de Bock, R ; Del Favero, A ; Bucaneve, G ; Crokaert, F ; Kern, W V ; Klastersky, J ; Langenaeken, I ; Micozzi, A ; Padmos, A ; Paesmans, M ; Viscoli, C ; Glauser, M P

Antimicrobial Agents and Chemotherapy, 1996-05, Vol.40 (5), p.1108-1115 [Periódico revisado por pares]

United States: American Society for Microbiology

Texto completo disponível